CA
CGN Advisors’s Medtronic MDT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
29,417
+701
| +2% | +$61.1K | 0.23% | 94 |
|
|
2025
Q1 | $2.58M | Sell |
28,716
-8,471
| -23% | -$761K | 0.25% | 90 |
|
|
2024
Q4 | $2.97M | Buy |
37,187
+4,601
| +14% | +$368K | 0.29% | 80 |
|
|
2024
Q3 | $2.93M | Sell |
32,586
-214
| -0.7% | -$19.3K | 0.3% | 82 |
|
|
2024
Q2 | $2.58M | Buy |
32,800
+2,142
| +7% | +$169K | 0.3% | 86 |
|
|
2024
Q1 | $2.67M | Buy |
30,658
+957
| +3% | +$83.4K | 0.34% | 73 |
|
|
2023
Q4 | $2.45M | Buy |
29,701
+3,020
| +11% | +$249K | 0.34% | 81 |
|
|
2023
Q3 | $2.09M | Buy |
26,681
+1,232
| +5% | +$96.5K | 0.28% | 92 |
|
|
2023
Q2 | $2.24M | Buy |
25,449
+1,512
| +6% | +$133K | 0.32% | 86 |
|
|
2023
Q1 | $1.93M | Buy |
23,937
+3,606
| +18% | +$291K | 0.3% | 88 |
|
|
2022
Q4 | $1.58M | Buy |
20,331
+8,095
| +66% | +$629K | 0.28% | 97 |
|
|
2022
Q3 | $988K | Buy |
12,236
+3,908
| +47% | +$316K | 0.25% | 110 |
|
|
2022
Q2 | $747K | Buy |
8,328
+2,398
| +40% | +$215K | 0.21% | 126 |
|
|
2022
Q1 | $658K | Buy |
5,930
+1,304
| +28% | +$145K | 0.16% | 126 |
|
|
2021
Q4 | $479K | Buy |
4,626
+134
| +3% | +$13.9K | 0.12% | 149 |
|
|
2021
Q3 | $563K | Buy |
4,492
+362
| +9% | +$45.4K | 0.18% | 125 |
|
|
2021
Q2 | $513K | Buy |
4,130
+125
| +3% | +$15.5K | 0.16% | 136 |
|
|
2021
Q1 | $473K | Buy |
4,005
+19
| +0.5% | +$2.24K | 0.17% | 125 |
|
|
2020
Q4 | $467K | Buy |
+3,986
| New | +$467K | 0.19% | 113 |
|